All ProductsDisplaying Products Alphabetically by Name (R)
| Cat. No. | Product Name / Activity |
|---|---|
| 6530 | R 121919 hydrochloride |
| High affinity CRF1 antagonist; orally bioavailable | |
| 5288 | R 268712 |
| Potent and selective inhibitor of TGF-βRI | |
| 5494 | R 547 |
| Potent and selective cdk inhibitor; orally bioavailable | |
| 3815 | R 568 hydrochloride |
| Positive allosteric modulator of human calcium-sensing receptor (CaSR) | |
| 5432 | R 7050 |
| Inhibitor of TNF-α receptor 1 signaling | |
| 1742 | R-96544 hydrochloride |
| Potent, selective 5-HT2A antagonist | |
| 2144 | R18 |
| Inhibitor of 14.3.3 proteins | |
| 7129 | RA 2 |
| Potent negative modulator of KCa2.3 and KCa3.1 channels | |
| 5707 | RA 839 |
| Nrf2 activator; inhibits Nrf2/Keap1 interaction | |
| 6649 | RADA |
| Orange-red TAMRA-based fluorescent D-amino acid for labeling peptidoglycans in live bacteria | |
| 7701 | RAGE 229 |
| ctRAGE-DIAPH1 interaction antagonist; reduces inflammatory signaling in diabetic mice | |
| 6259 | RAGE antagonist peptide |
| RAGE antagonist | |
| 7679 | RECTAS |
| IKBKAP pre-mRNA splicing modulator | |
| 3672 | RF 9 |
| Selective NPFF1 and NPFF2 antagonist | |
| 3295 | RG 108 |
| Non-nucleoside DNA methyltransferase inhibitor | |
| 7723 | RGD peptide |
| Minimal recognition sequence for integrin binding; potent integrin inhibitor | |
| 3498 | RGDS peptide |
| Integrin binding sequence; inhibits integrin receptor function | |
| 6728 | RGFP 966 |
| Potent and selective HDAC3 inhibitor | |
| 1842 | RHC 80267 |
| Diacylglycerol lipase inhibitor | |
| 5311 | RHPS 4 methosulfate |
| Telomerase inhibitor | |
| 7339 | RIPA 56 |
| Potent and metabolically stable RIP1 kinase inhibitor | |
| 6892 | RIPGBM |
| RIPK2 modulator; pro-drug of cRIPGM; orally bioavailable and brain penetrant | |
| 6603 | RIPK2 inhibitor 1 |
| Potent RIPK2 inhibitor | |
| 2443 | RITA |
| MDM2-p53 interaction inhibitor | |
| 1053 | RJR 2403 oxalate |
| Selective α4β2 nAChR agonist | |
| 5061 | RKI 1447 dihydrochloride |
| Potent and selective ROCK inhibitor; antitumor | |
| 8013 | RMR-Tre |
| Far-red fluorogenic trehalose probe for live mycobacteria imaging | |
| 4977 | RN 1 dihydrochloride |
| LSD1 inhibitor | |
| 3746 | RN 1734 |
| Selective TRPV4 antagonist | |
| 5678 | RN 9893 hydrochloride |
| Potent and selective TRPV4 antagonist | |
| 8813 | RNA Imaging Probe 1c |
| Fluorogenic RNA imaging probe | |
| 8835 | RNB 61 New |
| Highly potent and selective CB2R agonist | |
| 6833 | RO 5263397 hydrochloride |
| Potent TA1 receptor agonist | |
| 3052 | RO-3 |
| Selective P2X3 and P2X2/3 antagonist | |
| 4289 | RP 001 hydrochloride |
| Potent S1P1 agonist | |
| 8031 | RP 6306 |
| Potent and selective PKMYT1 inhibitor | |
| 1635 | RP 67580 |
| Potent and selective NK1 antagonist | |
| 1325 | RS 100329 hydrochloride |
| Potent, subtype-selective α1A antagonist | |
| 1050 | RS 102221 hydrochloride |
| Selective 5-HT2C antagonist | |
| 2089 | RS 102895 hydrochloride |
| CCR2b chemokine receptor antagonist | |
| 2993 | RS 127445 hydrochloride |
| High affinity and selective 5-HT2B antagonist | |
| 0985 | RS 17053 hydrochloride |
| α1A antagonist | |
| 0728 | RS 23597-190 hydrochloride |
| 5-HT4 antagonist | |
| 8853 | RS 246204 New |
| R-Spondin-1 substitute used to initiate small intestinal organoids | |
| 0991 | RS 39604 hydrochloride |
| 5-HT4 antagonist | |
| 2517 | RS 504393 |
| Highly selective CCR2 chemokine receptor antagonist | |
| 0987 | RS 79948 hydrochloride |
| Potent and selective α2 antagonist | |
| 6687 | 1R,3R-RSL3 |
| Negative control for 1S,3R-RSL3 (Cat. No. 6118) | |
| 6118 | 1S,3R-RSL3 |
| Inhibits glutathione peroxidase (GPX4); induces ferroptosis | |
| 0912 | RU 24969 hemisuccinate |
| 5-HT1A and 5-HT1B agonist | |
| 7904 | RU.521 |
| Potent and selective inhibitor of cyclic GMP-AMP synthase (cGAS) | |
| 8903 | RVG29-Cys New |
| Nicotinic acetylcholine receptor targeting peptide for neuronal delivery | |
| 2999 | RWJ 67657 |
| Potent, selective p38α and p38β inhibitor | |
| 1324 | RX 821002 hydrochloride |
| Potent, selective α2D antagonist | |
| 1810 | Raclopride |
| Potent and selective D2 and D3 antagonist | |
| 1589 | Radicicol |
| Hsp90 inhibitor. Antifungal antibiotic | |
| 2280 | Raloxifene hydrochloride |
| Selective estrogen receptor modulator (SERM) | |
| 3118 | Ranolazine dihydrochloride |
| Antianginal, activates pyruvate dehydrogenase | |
| 1292 | Rapamycin |
| mTOR inhibitor; immunosuppressant | |
| 4308 | Rasagiline mesylate |
| Selective and irreversible MAO-B inhibitor | |
| 1982 | Reboxetine mesylate |
| Potent and selective noradrenalin uptake inhibitor; orally active | |
| 7226 | Remdesivir |
| Viral RNA-dependent RNA polymerase (RdRP) inhibitor; broad spectrum antiviral nucleotide prodrug | |
| 3742 | RepSox |
| Potent and selective inhibitor of TGF-βRI | |
| TB3742-RMU | RepSox |
| RepSox synthesized to Ancillary Material Grade | |
| 3805 | Repaglinide |
| Kir6 (KATP) channel blocker | |
| 2742 | Reserpine |
| Inhibitor of vesicular monoamine transport | |
| 4536 | Resiquimod |
| Toll-like receptor 7 (TLR7) agonist | |
| 1418 | Resveratrol |
| Cyclooxygenase inhibitor | |
| 6233 | Retigabine |
| KV7 channel activator | |
| 0695 | Retinoic acid |
| Endogenous retinoic acid receptor agonist | |
| TB0695-RMU | Retinoic acid |
| Retinoic acid synthesized to Ancillary Material Grade | |
| 3722 | Reversan |
| Selective MRP1 and P-gp inhibitor | |
| 7406 | Rf470DL |
| Blue rotor-fluorogenic fluorescent D-amino acid for labeling peptidoglycans in live bacteria | |
| 5003 | Rhosin hydrochloride |
| Rho inhibitor | |
| 4501 | Ribavirin |
| Blocks eIF4E activity; antiviral guanosine analog | |
| 7050 | Ribociclib |
| Dual cdk4/cdk6 inhibitor; orally bioavailable | |
| 0790 | Rilmenidine hemifumarate |
| I1 ligand. Also α2 agonist | |
| 7684 | Rilpivirine |
| Non-nucleoside reverse transcriptase inhibitor | |
| 0768 | Riluzole hydrochloride |
| GABA uptake inhibitor; also inhibits glutamate release and blocks NaV channels | |
| 1497 | Rimcazole dihydrochloride |
| σ2 antagonist. Also DAT inhibitor | |
| 7916 | Risdiplam |
| Selective SMN2 gene splicing modifier | |
| 2865 | Risperidone |
| 5-HT2A antagonist; also D2 antagonist; atypical antipsychotic | |
| 1955 | Ritanserin |
| Potent 5-HT2 antagonist | |
| 5856 | Ritonavir |
| HIV-1 and HIV-2 protease inhibitor | |
| 4440 | Rivastigmine tartrate |
| Dual AChE and BChE inhibitor | |
| 2272 | Ro 08-2750 |
| Inhibits NGF binding to p75NTR and TrkA | |
| 1997 | Ro 15-4513 |
| Benzodiazepine partial inverse agonist | |
| 0415 | Ro 20-1724 |
| PDE4 inhibitor | |
| 1594 | Ro 25-6981 maleate |
| GluN2B-selective NMDA antagonist | |
| 2002 | Ro 31-8220 mesylate |
| Protein kinase inhibitor | |
| 1587 | Ro 32-0432 hydrochloride |
| Potent, orally active PKC inhibitor | |
| 4181 | Ro 3306 |
| Cdk1 inhibitor | |
| 5389 | Ro 48-8071 fumarate |
| 2,3-Oxidosqualene cyclase (OSC) inhibitor; blocks cholesterol synthesis | |
| 4694 | Ro 5-3335 |
| Core binding factor inhibitor; attenuates hematopoiesis | |
| 1854 | Ro 60-0175 fumarate |
| Potent, selective 5-HT2C agonist | |
| 3254 | Ro 61-8048 |
| Potent kynurenine 3-monooxygenase (KMO) inhibitor | |
| 2913 | Ro 64-5229 |
| Selective, non-competitive mGlu2 antagonist | |
| 4347 | Ro 67-4853 |
| Positive allosteric modulator of group I mGlu receptors | |
| 4346 | Ro 67-7476 |
| Positive allosteric modulator of mGlu1 receptors | |
| 5913 | Ro 6842262 |
| Potent LPA1 antagonist | |
| 2408 | Ro 90-7501 |
| Inhibitor of Aβ42 fibril formation | |
| 0905 | Rolipram |
| PDE4 inhibitor | |
| 1349 | (R)-(-)-Rolipram |
| PDE4 inhibitor. More active enantiomer of rolipram (Cat. No. 0905) | |
| 3680 | Ropinirole |
| Selective D2-like agonist | |
| 1332 | Roscovitine |
| 5325 | Rosiglitazone |
| Potent and selective PPARγ agonist; antidiabetic agent | |
| 5315 | Rostafuroxin |
| Na+/K+ ATPase modulator; antihypertensive agent | |
| 6343 | Rosuvastatin calcium |
| Potent HMG-CoA reductase inhibitor | |
| 3616 | Rotenone |
| Inhibits complex I of the mitochondrial electron transport chain | |
| 3896 | Rotigotine hydrochloride |
| D2 and D3 agonist | |
| 1610 | Rottlerin |
| Reported PKCδ inhibitor | |
| 7486 | Roxadustat |
| HIF-PH inhibitor; erythropoietic | |
| 3400 | RuBi-GABA |
| Caged GABA; excitable at visible wavelengths | |
| 3574 | RuBi-Glutamate |
| Caged glutamate; excited by visible wavelengths | |
| 4709 | RuBi GABA trimethylphosphine |
| Caged GABA; inhibits neural activity | |
| 6230 | Rucaparib camsylate |
| PARP inhibitor | |
| 3828 | Rufinamide |
| Prolongs inactivation of sodium channels; anticonvulsant | |
| 1439 | Ruthenium Red |
| Non-selective CaV2.1 and 2.2 blocker; also blocks TRPV channels | |
| 7064 | Ruxolitinib |
| Potent and selective JAK1/JAK2 inhibitor; orally bioavailable | |
| 7048 | Ruxolitinib phosphate |
| Phosphate salt of Ruxolitinib (Cat. No. 7064); potent and selective JAK1/JAK2 inhibitor | |
| 1329 | Ryanodine |
| Ca2+ release inhibitor | |
| 2609 | Ryuvidine |
| SETD8 inhibitor; also CDK4 inhibitor |
Tocris Products by Catalog Number
01000200030004000500060007000800090010001100120013001400150016001700180019002000210022002300240025002600270028002900300031003200330034003500360037003800390040004100420043004400450046004700480049005000510052005300540055005600570058005900600061006200630064006500660067006800690070007100720073007400750076007700780079008000810082008300840085008600870088008900